Timo Weiland
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Genomics, phytochemicals, and oxidative stress
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Cell death mechanisms and regulation 4
- Protein Degradation and Inhibitors 2
-
- Autophagy in Disease and Therapy 3
- Co-authors
- Ulrich M. Lauer (13 shared papers)Michael Bitzer (11 shared papers)Sascha Venturelli (9 shared papers)Alexander Berger (4 shared papers)Thomas S. Weiß (6 shared papers)Christian Busch (4 shared papers)Seema Noor (4 shared papers)Christian Leischner (4 shared papers)
- Journals
- PLoS ONE (4 papers)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Hepatology (1 paper)Gut (1 paper)
- Partner nations
- GermanySwitzerlandAustralia
In The Last Decade
Timo Weiland
21 papers receiving 606 citations
Peers
Comparison fields: 5 of 75
- Geriatrics and Gerontology 73
- Molecular Biology 380
- Genetics 134
- Biochemistry 28
- Oncology 108
Countries citing papers authored by Timo Weiland
This map shows the geographic impact of Timo Weiland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Weiland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Weiland more than expected).
Fields of papers citing papers by Timo Weiland
This network shows the impact of papers produced by Timo Weiland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Weiland. The network helps show where Timo Weiland may publish in the future.
Co-authors
The 25 scholars most cited alongside Timo Weiland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 143 | |
| 2 | 2012 | 88 | |
| 3 | 2013 | 86 | |
| 4 | 2013 | 52 | |
| 5 | 2013 | 47 | |
| 6 | 2013 | 45 | |
| 7 | 2013 | 34 | |
| 8 | 2010 | 19 | |
| 9 | 2013 | 18 | |
| 10 | 2022 | 15 | |
| 11 | 2011 | 13 | |
| 12 | [Prevalence of Borrelia burgdorferi antibodies in Hamburg blood donors]. | 1992 | 10 |
| 13 | 2010 | 9 | |
| 14 | 2008 | 7 | |
| 15 | 2007 | 7 | |
| 16 | 2011 | 7 | |
| 17 | 2010 | 7 | |
| 18 | 2011 | 4 | |
| 19 | IGG-CLASS ANTIBODIES TO HERPES-SIMPLEX VIRUS IN MARROW DONORS PREDISPOSE TO ACUTE GRAFT-VERSUS-HOST DISEASE | 1985 | 3 |
| 20 | 2012 | 2 |
About Timo Weiland
Timo Weiland is a scholar working on Molecular Biology, Epidemiology, Genetics, Immunology and Animal Science and Zoology, having authored 21 papers that have together received 617 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Virus-based gene therapy research (4 papers), Cell death mechanisms and regulation (4 papers), Animal Virus Infections Studies (3 papers), Autophagy in Disease and Therapy (3 papers), Diet, Metabolism, and Disease (2 papers), Protein Degradation and Inhibitors (2 papers) and Phagocytosis and Immune Regulation (2 papers). The work is most often cited by research in Geriatrics and Gerontology (73 citations), Molecular Biology (380 citations), Genetics (134 citations), Biochemistry (28 citations) and Oncology (108 citations). Timo Weiland has collaborated with scholars based in Germany, Switzerland and Australia. Frequent co-authors include Ulrich M. Lauer, Michael Bitzer, Sascha Venturelli, Alexander Berger, Thomas S. Weiß, Christian Busch, Seema Noor, Christian Leischner, Stephan C. Bischoff and Alexander Böcker. Their work appears in journals such as PLoS ONE, Molecular Cancer Therapeutics, Journal of Pharmacology and Experimental Therapeutics, Journal of Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.